Demonstrates enzymatic conversion of cysteine to aroma mercaptoketones, suggesting food industry applications.
Sulfur-containing aroma compounds, which are key determinants of the sensory profile and consumer acceptance of many foods, have received limited research attention regarding the liberation of these thiol aromas via exogenous enzymes. In this study, we characterized and successfully overexpressed an active cysteine-S-conjugate β-lyase (MetC) from the marine bacterium Shewanella putrefaciens, and we also established its optimal catalytic conditions. Kinetic analysis demonstrated effective activity of the enzyme toward natural substrates and aroma mercaptoketone precursors. Size-exclusion chromatography indicated a tetrameric structure for MetC. For most substrates, the apparent catalytic efficiency (Vₘₐₓ Vmax/Kₘ Km)app was calculated from the initial slopes of the velocity-concentration curves, which was used to evaluate catalytic efficiency due to solubility limits. Notably, only Cys-4MP-one reached saturation and conformed to sigmoidal model, indicating a unique cooperative behavior. These findings provide a quantitative basis for comparing the substrate specificity and catalytic effectiveness of MetC toward diverse precursors. The practical application of the enzyme was validated through preparative enzymatic conversion of cysteine-4-mercapto-4-methylpentan-2-one to 4-mercapto-4-methylpentan-2-one, with a 48.5% conversion achieved from its cysteine-conjugated precursor. Our findings demonstrate that S. putrefaciens MetC functions effectively as a biocatalyst for aroma thiol mercaptoketone production. Additionally, this research provides perspectives on the enzymatic production of sulfur-containing aroma compounds for applications in the fragrance and food industries. Key points • Eco-friendly enzymatic bioconversion produced aroma mercaptoketone. • Cysteine-S-conjugate β-lyase from Shewanella putrefaciens exhibited sigmoidal kinetics toward Cys-4MP-one, while other substrates followed linear kinetics. • A conversion of 48.5% was achieved for 4MMP during the preparative-scale biotransformation.
No takes yet. Share an insight, caveat, or question.
Huang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: